Date published: 2025-9-11

001 800-1338-3838

SCBT Portrait Logo
Seach Input

Lefty阻害剤

Lefty inhibitors belong to a distinct class of chemical compounds known for their pivotal role in regulating embryonic development and cell differentiation. These inhibitors are closely associated with the transforming growth factor-beta (TGF-β) superfamily of signaling molecules. To understand Lefty inhibitors, it's essential to appreciate their role within the intricate process of embryogenesis. During early development, Lefty inhibitors play a fundamental role in establishing the body plan of an organism. They are known for their function in maintaining symmetry and axis formation, a critical step in the early stages of embryonic development. Lefty inhibitors act as antagonists to certain signaling pathways within the TGF-β superfamily, exerting their influence by interfering with the signaling molecules involved. Specifically, they counteract the activity of Nodal, an important TGF-β member, which plays a key role in specifying the left-right axis in vertebrates. By doing so, Lefty inhibitors help ensure that the developing embryo forms with appropriate bilateral symmetry, preventing developmental abnormalities and ensuring the proper organization of vital organs.

Lefty inhibitors can be broadly classified into two isoforms: Lefty-1 and Lefty-2. Both isoforms exhibit similar mechanisms of action, working as negative regulators by binding to Nodal and inhibiting its signaling. This function is crucial for maintaining the balance of the Nodal pathway, preventing excessive or inappropriate signaling that could lead to developmental defects. Lefty inhibitors are a prime example of the delicate checks and balances that govern embryonic development. Their presence ensures the precise orchestration of signaling pathways, guaranteeing that an organism's body plan and symmetry are established correctly during its early stages of development. Understanding the mechanisms of Lefty inhibitors is not only essential for developmental biology but also holds potential implications for various fields of science and medicine, shedding light on the intricacies of cell signaling and differentiation.

関連項目

Items 1 to 10 of 15 total

画面:

製品名CAS #カタログ #数量価格引用文献レーティング

BIBF1120

656247-17-5sc-364433
sc-364433A
5 mg
10 mg
$180.00
$315.00
2
(0)

ニンテダニブは、VEGFR、FGFR、PDGFRなど複数の受容体を標的とするチロシンキナーゼ阻害剤で、血管新生と線維化の経路を阻害する。

Imatinib mesylate

220127-57-1sc-202180
sc-202180A
25 mg
100 mg
$44.00
$109.00
61
(1)

イマチニブはBCR-ABLチロシンキナーゼを阻害し、慢性骨髄性白血病(CML)や消化管間質腫瘍(GIST)における異常なシグナル伝達を阻止する。

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

この化合物は広く転写を阻害し、LEFTYを含む多くの遺伝子の発現を低下させる可能性がある。

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

ソラフェニブはRAFおよびVEGFRキナーゼを標的とし、細胞の増殖と拡散に関与するMAPKおよびVEGF経路を阻害する。

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$74.00
$119.00
33
(1)

エルロチニブはEGFRチロシンキナーゼを阻害し、細胞増殖と細胞分裂の促進に関与する下流のシグナル伝達経路を遮断する。

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

LEFTYタンパク質合成を減少させる可能性のあるタンパク質翻訳阻害剤。

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

スニチニブはVEGFR、PDGFR、その他のキナーゼを阻害し、血管新生と腫瘍細胞の増殖を阻害する。

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

ゲフィチニブはEGFRチロシンキナーゼ阻害剤であり、EGFRが駆動するシグナル伝達経路を阻害することにより、細胞の増殖と分裂を停止させる。

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

ダサチニブはBCR-ABLと他のキナーゼを標的として白血病細胞の増殖を抑制し、主に慢性骨髄性白血病(CML)に用いられる。

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$35.00
$115.00
$515.00
26
(1)

WntシグナルとTGF-βシグナルのクロストークを考えると、XAV-939やICG-001のような阻害剤は、間接的にLEFTYの発現や活性を調節しているのかもしれない。